What is the price target for CNMD stock?
12 analysts have analysed CNMD and the average price target is 48.35 USD. This implies a price increase of 35.43% is expected in the next year compared to the current price of 35.7.
CONMED CORP (CNMD) Forecast, Price Target & Analyst Ratings
NYSE:CNMD • US2074101013
Current stock price
35.7 USD
-0.94 (-2.57%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CONMED CORP (CNMD).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Apr 28, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.84
- Revenue Estimate
- 316.72M
Price Target Details & History
Consensus Price Target and Range
Mean target
$48.35
Upside
+ 35.43%
From current price of $35.70 to mean target of $48.35, Based on 12 analyst forecasts
Low
$42.42
Median
$45.90
High
$57.75
Price Target Revisions
1 Month
-2.47%
3 Months
-2.07%
Price Target Summary
12 Wall Street analysts provided a forecast for the next 12 months for CNMD. The average price target is 48.35 USD. This implies a price increase of 35.43% is expected in the next year compared to the current price of 35.7.
The average price target has been revised downward by 2.07% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
73.33%
CNMD was analyzed by 12 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about CNMD.
In the previous month the buy percentage consensus was at a similar level.
CNMD was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-17 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2026-01-29 | Needham | Reiterate | Hold -> Hold |
| 2026-01-29 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-08 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-11-06 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-06 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-11-06 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-07-31 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-06-12 | Needham | Downgrade | Buy -> Hold |
| 2025-05-01 | Needham | Maintains | Buy -> Buy |
| 2025-05-01 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-01 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-04-28 | Stifel | Downgrade | Buy -> Hold |
| 2025-02-06 | Needham | Maintains | Buy -> Buy |
| 2025-02-06 | Stifel | Maintains | Buy -> Buy |
| 2025-02-06 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-06 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-10-31 | Needham | Reiterate | Buy -> Buy |
| 2024-10-04 | Needham | Reiterate | Buy -> Buy |
| 2024-08-01 | Needham | Maintains | Buy -> Buy |
| 2024-08-01 | Stifel | Maintains | Buy -> Buy |
| 2024-08-01 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-08-01 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-07-25 | Needham | Maintains | Buy -> Buy |
| 2024-05-06 | Needham | Reiterate | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 28, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.84
- Revenue Estimate
- 316.72M
- Revenue Q2Q
- -1.41%
- EPS Q2Q
- -12.07%
- Number of Analysts
- 8
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-5.91%
EPS (1 Month)
0.00%
EPS (3 Months)
-12.72%
Next Earnings Summary
CNMD is expected to report earnings on 4/28/2026. The consensus EPS estimate for the next earnings is 0.84 USD and the consensus revenue estimate is 316.72M USD.
The next earnings revenue estimate has been revised downward by 5.91% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates 2026 - 2028
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.245B 19.06% | 1.307B 5.00% | 1.375B 5.18% | 1.386B 0.82% | 1.462B 5.48% | 1.55B 6.02% | |
| EBITDA YoY % growth | 193.277M 38.35% | 281.059M 45.42% | 179.903M -35.99% | 272.75M 51.61% | 298.8M 9.55% | 321.3M 7.53% | |
| EBIT YoY % growth | 121.403M 73.19% | 209.202M 72.32% | 105.622M -49.51% | 208.93M 97.81% | 227.72M 8.99% | 245.03M 7.60% | |
| Operating Margin | 9.75% | 16.01% | 7.68% | 15.07% | 15.58% | 15.81% | |
| EPS YoY % growth | 3.45 30.19% | 4.16 20.58% | 4.61 10.82% | 4.44 -3.63% | 5.03 13.12% | 5.66 12.64% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.84 -12.07% | 1.11 -3.32% | 1.05 -3.19% | 1.36 -4.95% | 1.07 27.72% | 1.23 10.28% | 1.08 2.83% | 1.42 4.84% |
| Revenue Q2Q % growth | 316.72M -1.41% | 347.44M 1.49% | 346.6M 2.57% | 392.68M 5.22% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 56.196M 42.26% | 68.289M -18.86% | 61.414M -8.76% | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 38.97M 83.40% | 49.925M 5.45% | 53.206M 347.90% | 74.221M 112.94% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
7.09%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
3.55%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
14.30%
EBIT Next 5 Year
N/A
CONMED CORP / CNMD Forecast FAQ
Can you provide the upcoming earnings date for CONMED CORP?
CONMED CORP (CNMD) will report earnings on 2026-04-28, after the market close.
What are the consensus estimates for CONMED CORP (CNMD) next earnings?
The consensus EPS estimate for the next earnings of CONMED CORP (CNMD) is 0.84 USD and the consensus revenue estimate is 316.72M USD.
How many analysts cover CONMED CORP (CNMD) stock?
The number of analysts covering CONMED CORP (CNMD) is 12.